{"id":"W4360599615","doi":"10.3324/haematol.2023.282791","title":"Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University; Jewish General Hospital","funders":"Janssen Pharmaceuticals; Genentech; Fondation de l'Hôpital général juif; Leukemia and Lymphoma Society; Jazz Pharmaceuticals; F. Hoffmann-La Roche; Gilead Sciences; Jewish General Hospital; Sanofi","keywords":"Decitabine; Cytarabine; Myeloid leukemia; Pharmacology; Medicine; Internal medicine; Deoxycytidine kinase; Oncology; Cancer research; Biology; Deoxycytidine; Chemotherapy; Gemcitabine; Biochemistry; Gene expression","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004755346,0.0003037394,0.0008677901,0.0001344183,0.0000894905,0.00001183094,0.0003037166,0.0002684977,0.00003379989],"category_scores_gemma":[0.0005206685,0.0001900198,0.000223942,0.0004596101,0.0002358713,0.00002116422,0.00005993118,0.000191842,0.000001332279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000533664,"about_ca_system_score_gemma":0.0002933857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005074747,"about_ca_topic_score_gemma":0.00003141031,"domain_scores_codex":[0.9974309,0.0005450835,0.0008804644,0.0004550839,0.0003791871,0.0003092686],"domain_scores_gemma":[0.9986746,0.0002059018,0.0004879275,0.0003974471,0.0001771161,0.00005695559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.4832106,0.0008776219,0.00170277,0.0001594069,0.0003997783,0.00002842868,0.0008691679,0.002107256,0.5091377,0.0001642673,0.0000718866,0.001271039],"study_design_scores_gemma":[0.3675312,0.003247265,0.0003941797,0.0001643725,0.0001967925,0.00000424151,0.00005005774,0.001104594,0.6268529,0.00009182598,0.00007380849,0.0002887701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943403,0.0002736859,0.003132461,0.0001037205,0.0001963868,0.001751161,0.0001227816,0.00003492683,0.00004457942],"genre_scores_gemma":[0.9983211,0.0001878418,0.0007436563,0.00006494505,0.00003616366,0.0002271981,0.0003639782,0.00003950589,0.00001557139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1177151,"threshold_uncertainty_score":0.7748784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01726773215579263,"score_gpt":0.2759986050334017,"score_spread":0.258730872877609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}